BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26497847)

  • 1. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma.
    Tang B; Liang X; Tang F; Zhang J; Zeng S; Jin S; Zhou L; Kudo Y; Qi G
    Int J Oncol; 2015 Dec; 47(6):2208-16. PubMed ID: 26497847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High USP22 expression indicates poor prognosis in hepatocellular carcinoma.
    Tang B; Tang F; Li B; Yuan S; Xu Q; Tomlinson S; Jin J; Hu W; He S
    Oncotarget; 2015 May; 6(14):12654-67. PubMed ID: 25909224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-specific protease 11 serves as a marker of poor prognosis and promotes metastasis in hepatocellular carcinoma.
    Zhang S; Xie C; Li H; Zhang K; Li J; Wang X; Yin Z
    Lab Invest; 2018 Jul; 98(7):883-894. PubMed ID: 29545598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
    Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R
    Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
    Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
    Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
    Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
    BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
    Wen X; Ling S; Wu W; Shan Q; Liu P; Wang C; Wei X; Ding W; Teng X; Xu X
    Dig Dis Sci; 2020 Apr; 65(4):1064-1073. PubMed ID: 31587155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
    Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
    BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).
    Yang Y; Zhu J; Gou H; Cao D; Jiang M; Hou M
    Med Oncol; 2011 Sep; 28(3):796-803. PubMed ID: 20401641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.
    Ling S; Li J; Shan Q; Dai H; Lu D; Wen X; Song P; Xie H; Zhou L; Liu J; Xu X; Zheng S
    Mol Oncol; 2017 Jun; 11(6):682-695. PubMed ID: 28417539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.
    Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.
    Sun X; Jin Z; Song X; Wang J; Li Y; Qian X; zhang Y; Yin Y
    BMC Cancer; 2015 Dec; 15():961. PubMed ID: 26674738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of Survivin and NF-κB associated with prognostically worse clinicopathologic variables in hepatocellular carcinoma.
    Jin Y; Chen J; Feng Z; Fan W; Wang Y; Li J; Tong D
    Tumour Biol; 2014 Oct; 35(10):9905-10. PubMed ID: 24996542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
    Zhuang YJ; Liao ZW; Yu HW; Song XL; Liu Y; Shi XY; Lin XD; Zhou TC
    Cancer Biol Ther; 2015; 16(1):88-96. PubMed ID: 25482932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
    Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.
    Zhang Y; Yao L; Zhang X; Ji H; Wang L; Sun S; Pang D
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1245-53. PubMed ID: 21691749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.